These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8586759)

  • 1. Successful treatment of vitiligo with a sex steroid-thyroid hormone mixture.
    Muto M; Furumoto H; Ohmura A; Asagami C
    J Dermatol; 1995 Oct; 22(10):770-2. PubMed ID: 8586759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of ACTH and alpha-MSH in vitiligo patients successfully treated with a sex steroid-thyroid hormone mixture.
    Ichimiya M
    J Dermatol; 1999 Aug; 26(8):502-6. PubMed ID: 10487004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of non-segmental vitiligo: systemic therapy with sex hormone-thyroid powder mixture.
    Nagai K; Ichimiya M; Yokoyama K; Hamamoto Y; Muto M
    Horm Res; 2000; 54(5-6):316-7. PubMed ID: 11595825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metharmon F for glossalgia caused by autonomic dysfunction].
    Densho S; Ohama G; Yamamoto E; Komatsu Y; Genba R
    Shikai Tenbo; 1985 Aug; 66(2):455-60. PubMed ID: 3866331
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical effects of metharmon F for postmenopausal women with climacteric symptoms: its relationship with serum level of hormones].
    Yoshimoto S; Fujita T
    Horumon To Rinsho; 1983 Aug; 31(8):815-22. PubMed ID: 6414748
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of estrogen and, sex-steroids and thyroid hormone preparation on bone mineral density in senile osteoporosis--a comparative study of the effect of 1 alpha-hydroxycholecalciferol (1 alpha-OHD3) on senile osteoporosis].
    Shiraki M; Orimo H
    Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):84-95. PubMed ID: 1645679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reagents inducing epidermal proliferation also induce pigmentation: induction of keratinocyte proliferation as a novel strategy for the treatment of vitiligo.
    Wu CS; Komine M; Fujimoto S; Ohmatsu H; Kikuchi K; Tada Y; Yu HS; Ohtsuki M; Tamaki K
    J Dermatol Sci; 2013 Oct; 72(1):66-8. PubMed ID: 23876305
    [No Abstract]   [Full Text] [Related]  

  • 8. Differences in the melanosome distribution within the epidermal melanin units and its association with the impairing background of leukoderma in vitiligo and halo nevi: a retrospective study.
    Xiong XX; Ding GZ; Zhao WE; Li X; Ling YT; Sun L; Gong QL; Lu Y
    Arch Dermatol Res; 2017 Jul; 309(5):323-333. PubMed ID: 28314912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic update on vitiligo.
    Sarnoff DS
    J Drugs Dermatol; 2015 Feb; 14(2):109-11. PubMed ID: 25689803
    [No Abstract]   [Full Text] [Related]  

  • 10. Giant melanin granules in vitiliginous achromia with malignant melanoma.
    Ortonne JP; Perrot H
    Acta Derm Venereol; 1978; 58(6):475-80. PubMed ID: 83067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model.
    Faas L; Venkatasamy R; Hider RC; Young AR; Soumyanath A
    Br J Dermatol; 2008 May; 158(5):941-50. PubMed ID: 18284389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo.
    Lan CC; Chen GS; Chiou MH; Wu CS; Chang CH; Yu HS
    Br J Dermatol; 2005 Sep; 153(3):498-505. PubMed ID: 16120133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of melanocye-keratinocyte co-culture model for controls and vitiligo to assess regulators of pigmentation and melanocytes.
    Kumar R; Parsad D; Kanwar A; Kaul D
    Indian J Dermatol Venereol Leprol; 2012; 78(5):599-604. PubMed ID: 22960816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of an antioxidant and mitochondria-stimulating cream formula on the skin of patients with stable common vitiligo].
    Rojas-Urdaneta JE; Poleo-Romero AG
    Invest Clin; 2007 Mar; 48(1):21-31. PubMed ID: 17432541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of localized, resistant, tingling vitiligo to pregabalin: A case report.
    Madura C; Harsha S; Kusuma MR; Chandrashekar BS
    Dermatol Ther; 2018 Nov; 31(6):e12702. PubMed ID: 30456812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation.
    Hariharan V; Klarquist J; Reust MJ; Koshoffer A; McKee MD; Boissy RE; Le Poole IC
    J Invest Dermatol; 2010 Jan; 130(1):211-20. PubMed ID: 19657355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RALGA (Diacneal) decreases melanin content in a human skin model.
    Boisnic S; Branchet-Gumila MC; Nocera T; Verrière F
    Dermatology; 2005; 210 Suppl 1():35-8. PubMed ID: 15724106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitiligo: new and emerging treatments.
    Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
    Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eumelanin and phaeomelanin contents of depigmented and repigmented skin in vitiligo patients.
    Parsad D; Wakamatsu K; Kanwar AJ; Kumar B; Ito S
    Br J Dermatol; 2003 Sep; 149(3):624-6. PubMed ID: 14510999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir.
    Dogra S; Kumar B
    Dermatol Online J; 2005 Dec; 11(3):30. PubMed ID: 16409926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.